TSX: ACB
EDMONTON, April 13, 2018 /CNW/ - Aurora Cannabis Inc.
("Aurora") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) today announced
the successful delivery of the first ever batch of privately
exported medical cannabis from Canada to the Italian government through its
wholly-owned German subsidiary Pedanios GmbH. Following the
successful delivery, the products have now been distributed to
Italian Pharmacies.
Today's announcement follows the company's press release of
January 18, 2018, which announced
that Aurora and Pedanios had won a highly-competitive EU-wide
public tender to supply 100kg of medical cannabis to the Italian
government through the Italian Ministry of Defense, who oversee
medical cannabis production and distribution in Italy.
"The Italian government has entrusted Aurora as the only direct,
foreign non-government supplier to the Department of Defense in
response to its first ever public tender to help support the
growing demand on its strictly-regulated medical cannabis program,"
said Terry Booth, CEO. "We take this
responsibility very seriously, and will be supporting the growing
number of patients in the Italian system with high-quality
products, as well as educational support initiatives for both the
general public and physicians. The Aurora Standard reflects a
level of professionalism, product quality and patient care that is
increasingly recognized by a growing number of international
governments, physicians, pharmacies and patients."
Aurora's Chief Global Business Development Officer, Neil Belot, added, "We are extremely proud to
become the first non-government supplier to the Italian market.
This historic first shipment of premium quality, EU GMP-certified
medical cannabis provides Aurora with a first and highly visible
foothold in a market with over 60 million people. With nation-wide
coverage in place for the cost of cannabis, we anticipate rapid
growth, and look forward to establishing the Aurora Standard as the
benchmark in this exciting market."
About Aurora
Aurora's wholly-owned subsidiary, Aurora Cannabis Enterprises
Inc., is a licensed producer of medical cannabis pursuant to Health
Canada's Access to Cannabis for Medical Purposes Regulations
("ACMPR"). The Company operates a 55,200 square foot,
state-of-the-art production facility in Mountain View County,
Alberta, known as "Aurora
Mountain", and a second 40,000 square foot high-technology
production facility known as "Aurora Vie" in Pointe-Claire, Quebec on Montreal's West Island. In January 2018, Aurora's 800,000 square foot
flagship cultivation facility, Aurora Sky, located at the
Edmonton International Airport,
was licensed. Once at full capacity, Aurora Sky is expected to
produce over 100,000 kg per annum of cannabis. Aurora is
completing a facility in Lachute,
Quebec utilizing its wholly owned subsidiary Aurora Larssen
Projects Inc.
Aurora is close to completion of the acquisition of all the
outstanding shares of CanniMed Therapeutics Inc, Canada's most experienced licensed producer of
medical cannabis, adding over 20,000 kg per annum in funded
capacity, as well as Canada's
strongest medical cannabis brand.
Aurora also owns Berlin-based
Pedanios, the leading wholesale importer, exporter, and distributor
of medical cannabis in the European Union. The Company owns 51% of
Aurora Nordic, which will be constructing a 1,000,000 square foot
hybrid greenhouse in Odense,
Denmark. The Company offers further differentiation through
its acquisition of BC Northern Lights Ltd. and Urban Cultivator
Inc., industry leaders, respectively, in the production and sale of
proprietary systems for the safe, efficient and high-yield indoor
cultivation of cannabis, and in state-of-the-art indoor gardening
appliances for the cultivation of organic microgreens, vegetables
and herbs in home and professional kitchens.
Aurora holds a 19.88% ownership interest in Liquor Stores N.A.,
("LIQ") who are developing a cannabis retail network in
Western Canada. In addition, the
Company holds approximately 17.23% of the issued shares in leading
extraction technology company Radient Technologies Inc, and has a
strategic investment in Hempco Food and Fiber Inc., with options to
increase ownership stake to over 50%. Aurora is also the
cornerstone investor in two other licensed producers, with a 22.9%
stake in Cann Group Limited, the first Australian company licensed
to conduct research on and cultivate medical cannabis, and a 17.62%
stake in Canadian producer The Green Organic Dutchman Ltd., with
options to increase to majority ownership.
Aurora's Common Shares trade on the TSX under the symbol "ACB",
and are a constituent of the S&P/TSX Composite Index
On behalf of the Boards of
Directors,
AURORA CANNABIS INC.
Terry Booth
CEO
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable
securities law ("forward-looking statements"). Forward-looking
statements are frequently characterized by words such as "plan",
"continue", "expect", "project", "intend", "believe", "anticipate",
"estimate", "may", "will", "potential", "proposed" and other
similar words, or statements that certain events or conditions
"may" or "will" occur. These statements are only predictions.
Various assumptions were used in drawing the conclusions or making
the projections contained in the forward-looking statements
throughout this news release. Forward-looking statements are based
on the opinions and estimates of management at the date the
statements are made, and are subject to a variety of risks and
uncertainties and other factors that could cause actual events or
results to differ materially from those projected in the
forward-looking statements. The Company is under no obligation, and
expressly disclaims any intention or obligation, to update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise, except as expressly
required by applicable law.
Neither TSX nor its Regulation Services Provider (as that
term is defined in the policies of Toronto Stock Exchange) accepts
responsibility for the adequacy or accuracy of this
release.
SOURCE Aurora Cannabis Inc.